{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:57:24Z","timestamp":1772121444544,"version":"3.50.1"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR075241"],"award-info":[{"award-number":["R01 AR075241"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA284075"],"award-info":[{"award-number":["R01 CA284075"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA031452"],"award-info":[{"award-number":["R01AA031452"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R00AA025393"],"award-info":[{"award-number":["R00AA025393"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R21AA030862"],"award-info":[{"award-number":["R21AA030862"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008562","name":"University of Texas at Austin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R00 DA035865"],"award-info":[{"award-number":["R00 DA035865"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neuropharm.2025.110502","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T18:30:39Z","timestamp":1746988239000},"page":"110502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Chronic intermittent ethanol produces nociception through endocannabinoid-independent mechanisms in mice"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4042-468X","authenticated-orcid":false,"given":"Cristina","family":"Miliano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4573-0114","authenticated-orcid":false,"given":"Yuyang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"McKenzie","family":"Proffit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia Corvalan","family":"Cabanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9837-4670","authenticated-orcid":false,"given":"Luis A.","family":"Natividad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6851-1382","authenticated-orcid":false,"given":"Matthew W.","family":"Buczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M.","family":"Gregus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110502_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2020.100052","article-title":"Chronic inflammatory pain alters alcohol-regulated frontocortical signaling and associations between alcohol drinking and thermal sensitivity","volume":"8","author":"Adrienne McGinn","year":"2020","journal-title":"Neurobiol Pain"},{"key":"10.1016\/j.neuropharm.2025.110502_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.chembiol.2009.02.013","article-title":"Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain","volume":"16","author":"Ahn","year":"2009","journal-title":"Chem Biol"},{"key":"10.1016\/j.neuropharm.2025.110502_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109354","article-title":"Sex-specific differences in alcohol-induced pain sensitization","volume":"225","author":"Alexander","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110502_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2016.08.017","article-title":"Involvement of delta opioid receptors in alcohol withdrawal-induced mechanical allodynia in male C57BL\/6 mice","volume":"167","author":"Alongkronrusmee","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110502_bib5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/adb.12365","article-title":"Oleoylethanolamide prevents neuroimmune HMGB1\/TLR4\/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration","volume":"22","author":"Anton","year":"2017","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib6","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/adb.12580","article-title":"Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women","volume":"23","author":"Anton","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib7","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1523\/JNEUROSCI.0483-18.2018","article-title":"Central amygdala circuits mediate hyperalgesia in alcohol-dependent rats","volume":"38","author":"Avegno","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110502_bib8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/acer.14582","article-title":"Heritability of ethanol consumption and pharmacokinetics in a genetically diverse panel of collaborative cross mouse strains and their inbred founders","volume":"45","author":"Bagley","year":"2021","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110502_bib9","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/01.ALC.0000149977.95306.3A","article-title":"Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL\/6 mice","volume":"28","author":"Becker","year":"2004","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110502_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S0140525X97221485","article-title":"Sex differences in pain","volume":"20","author":"Berkley","year":"1997","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.neuropharm.2025.110502_bib11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/adb.12276","article-title":"Role of the satiety factor oleoylethanolamide in alcoholism","volume":"21","author":"Bilbao","year":"2016","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.alcohol.2018.05.009","article-title":"Characterizing chronic pain and alcohol use trajectory among treatment-seeking alcoholics","volume":"75","author":"Boissoneault","year":"2019","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2025.110502_bib13","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1476-5381.2011.01445.x","article-title":"The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice","volume":"165","author":"Booker","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib14","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/bph.16091","article-title":"Chronic alcohol induced mechanical allodynia by promoting neuroinflammation: a mouse model of alcohol-evoked neuropathic pain","volume":"180","author":"Borgonetti","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107462","article-title":"Excessive alcohol intake produces persistent mechanical allodynia and dysregulates the endocannabinoid system in the lumbar dorsal root ganglia of genetically-selected Marchigian Sardinian alcohol-preferring rats","volume":"209","author":"Borgonetti","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2025.110502_bib16","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jpain.2023.02.024","article-title":"Mechanical and heat hyperalgesia upon withdrawal from chronic intermittent ethanol vapor depends on sex, exposure duration, and blood alcohol concentration in mice","volume":"24","author":"Brandner","year":"2023","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2025.110502_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1360-0443.2005.01074.x","article-title":"Pain and use of alcohol to manage pain: prevalence and 3-year outcomes among older problem and non-problem drinkers","volume":"100","author":"Brennan","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2025.110502_bib18","article-title":"12\/15-Lipoxygenases mediate neuropathic-like pain hypersensitivity in female mice","author":"Brown","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuropharm.2025.110502_bib19","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/j.pain.0000000000001306","article-title":"Targeting toll-like receptor-4 (TLR4)-an emerging therapeutic target for persistent pain states","volume":"159","author":"Bruno","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2025.110502_bib20","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.joca.2015.05.001","article-title":"Deficits in spontaneous burrowing behavior in the rat bilateral monosodium iodoacetate model of osteoarthritis: an objective measure of pain-related behavior and analgesic efficacy","volume":"23","author":"Bryden","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.neuropharm.2025.110502_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090013","article-title":"Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4\/MyD88-dependent cytokine cascade in the mice paw","volume":"9","author":"Calil","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110502_bib22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.7326\/M17-3065","article-title":"Patterns of potential opioid misuse and subsequent adverse outcomes in medicare, 2008 to 2012","volume":"168","author":"Carey","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuropharm.2025.110502_bib23","article-title":"Antagonists of the stress and opioid systems restore the functional connectivity of the prefrontal cortex during alcohol withdrawal through divergent mechanisms","author":"Carrette","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuropharm.2025.110502_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40122-021-00244-1","article-title":"Pain in women: a perspective review on a relevant clinical issue that deserves prioritization","volume":"10","author":"Casale","year":"2021","journal-title":"Pain Ther"},{"key":"10.1016\/j.neuropharm.2025.110502_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2025.110502_bib26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00000542-199510000-00017","article-title":"Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats","volume":"83","author":"Chaplan","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2025.110502_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1744-8069-3-5","article-title":"Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat","volume":"3","author":"Chen","year":"2007","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2025.110502_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2023.100135","article-title":"NAPE-PLD regulates specific baseline affective behaviors but is dispensable for inflammatory hyperalgesia","volume":"14","author":"Chen","year":"2023","journal-title":"Neurobiol Pain"},{"key":"10.1016\/j.neuropharm.2025.110502_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2125.2011.04111.x","article-title":"Alcoholic neuropathy: possible mechanisms and future treatment possibilities","volume":"73","author":"Chopra","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1124\/jpet.117.245704","article-title":"Monoacylglycerol lipase inhibitors reverse paclitaxel-induced nociceptive behavior and proinflammatory markers in a mouse model of chemotherapy-induced neuropathy","volume":"366","author":"Curry","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110502_bib31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3399\/bjgp16X684433","article-title":"The dangers of NSAIDs: look both ways","volume":"66","author":"Davis","year":"2016","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.neuropharm.2025.110502_bib32","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1172\/JCI128022","article-title":"Schwann cells expressing nociceptive channel TRPA1 orchestrate ethanol-evoked neuropathic pain in mice","volume":"129","author":"De Logu","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2025.110502_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0741-8329(94)00098-X","article-title":"Sex- and strain-related differences in first-pass alcohol metabolism in mice","volume":"12","author":"Desroches","year":"1995","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2025.110502_bib34","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/01.ALC.0000089959.66222.B8","article-title":"Dopamine activity in the nucleus accumbens during consummatory phases of oral ethanol self-administration","volume":"27","author":"Doyon","year":"2003","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110502_bib35","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.neuropharm.2011.11.006","article-title":"Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: alleviation by CRF1 receptor antagonism","volume":"62","author":"Edwards","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110502_bib36","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.neubiorev.2012.07.010","article-title":"Alcohol dependence as a chronic pain disorder","volume":"36","author":"Egli","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110502_bib37","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/acer.12686","article-title":"Chronic intermittent ethanol exposure in mice leads to an up-regulation of CRH\/CRHR1 signaling","volume":"39","author":"Eisenhardt","year":"2015","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110502_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.08.023","article-title":"Sex and gender-related differences in alcohol use and its consequences: contemporary knowledge and future research considerations","volume":"156","author":"Erol","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110502_bib39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41398-021-01337-3","article-title":"Endocannabinoid signaling in the lateral habenula regulates pain and alcohol consumption","volume":"11","author":"Fu","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110502_bib40","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/adb.12408","article-title":"Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence","volume":"22","author":"Garcia-Marchena","year":"2017","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib41","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.lfs.2012.06.020","article-title":"The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model","volume":"92","author":"Ghosh","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2025.110502_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1124\/jpet.115.222851","article-title":"Full fatty acid amide hydrolase inhibition combined with partial monoacylglycerol lipase inhibition: augmented and sustained antinociceptive effects with reduced cannabimimetic side effects in mice","volume":"354","author":"Ghosh","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110502_bib43","first-page":"185","article-title":"Neurobiology of alcohol dependence: focus on motivational mechanisms","volume":"31","author":"Gilpin","year":"2008","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.neuropharm.2025.110502_bib44","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/ALN.0000000000002615","article-title":"Elevation of transient receptor potential vanilloid 1 function in the lateral habenula mediates aversive behaviors in alcohol-withdrawn rats","volume":"130","author":"Gregor","year":"2019","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2025.110502_bib45","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1097\/j.pain.0000000000001373","article-title":"Inhibition of spinal 15-LOX-1 attenuates TLR4-dependent, nonsteroidal anti-inflammatory drug-unresponsive hyperalgesia in male rats","volume":"159","author":"Gregus","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2025.110502_bib46","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/j.pain.0000000000002215","article-title":"Sex differences in neuroimmune and glial mechanisms of pain","volume":"162","author":"Gregus","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2025.110502_bib47","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1476-5381.2010.01192.x","article-title":"Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain","volume":"163","author":"Guindon","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib48","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1037\/adb0000416","article-title":"Marijuana use is associated with alcohol use and consequences across the first 2 years of college","volume":"32","author":"Gunn","year":"2018","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.neuropharm.2025.110502_bib49","first-page":"633","article-title":"Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes","volume":"9","author":"Guy","year":"2013","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib50","doi-asserted-by":"crossref","first-page":"16362","DOI":"10.1523\/JNEUROSCI.1392-15.2015","article-title":"Sex differences in nucleus accumbens transcriptome profiles associated with susceptibility versus resilience to subchronic variable stress","volume":"35","author":"Hodes","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110502_bib51","first-page":"181","article-title":"Male and female sensitivity to alcohol-induced brain damage","volume":"27","author":"Hommer","year":"2003","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.neuropharm.2025.110502_bib52","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.neuroscience.2008.04.014","article-title":"The shell of the nucleus accumbens has a higher dopamine response compared with the core after non-contingent intravenous ethanol administration","volume":"154","author":"Howard","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110502_bib53","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1038\/s41467-023-43606-3","article-title":"A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence","volume":"14","author":"Jiang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110502_bib54","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ejpain.2009.11.008","article-title":"Increased pain sensitivity in alcohol withdrawal syndrome","volume":"14","author":"Jochum","year":"2010","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2025.110502_bib55","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1111\/add.15407","article-title":"Effects of cannabis use on alcohol consumption in a sample of treatment-engaged heavy drinkers in Colorado","volume":"116","author":"Karoly","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2025.110502_bib56","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pain.2004.02.027","article-title":"Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament","volume":"109","author":"Kim","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2025.110502_bib57","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jpain.2010.04.001","article-title":"Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms","volume":"11","author":"Kinsey","year":"2010","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2025.110502_bib58","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1212\/WNL.56.12.1727","article-title":"Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status","volume":"56","author":"Koike","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2025.110502_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.10550","article-title":"Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy","volume":"54","author":"Koike","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib60","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0153-18.2018","article-title":"Systemic and intra-habenular activation of the orphan G protein-coupled receptor GPR139 decreases compulsive-like alcohol drinking and hyperalgesia in alcohol-dependent rats","volume":"5","author":"Kononoff","year":"2018","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2025.110502_bib61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-pharmtox-031323-115847","article-title":"Alcohol use disorder treatment: problems and solutions","volume":"64","author":"Koob","year":"2024","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib62","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2125.2011.04137.x","article-title":"Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects","volume":"73","author":"Li","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.alcohol.2015.11.010","article-title":"Effect of different stressors on voluntary ethanol intake in ethanol-dependent and nondependent C57BL\/6J mice","volume":"51","author":"Lopez","year":"2016","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2025.110502_bib64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.alcohol.2023.01.003","article-title":"Agmatine reduces alcohol drinking and produces antinociceptive effects in rodent models of alcohol use disorder","volume":"109","author":"Lopez","year":"2023","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2025.110502_bib65","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/pm\/pnaa396","article-title":"Cannabis significantly reduces the use of prescription opioids and improves quality of life in authorized patients: results of a large prospective study","volume":"22","author":"Lucas","year":"2021","journal-title":"Pain Med."},{"key":"10.1016\/j.neuropharm.2025.110502_bib66","first-page":"24","article-title":"Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults","volume":"18","author":"Marcum","year":"2010","journal-title":"Ann. Long Term Care"},{"key":"10.1016\/j.neuropharm.2025.110502_bib67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.35946\/arcr.v41.1.07","article-title":"Alcohol use disorder: the role of medication in recovery","volume":"41","author":"Mason","year":"2021","journal-title":"Alcohol Res"},{"key":"10.1016\/j.neuropharm.2025.110502_bib68","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.2023.19761","article-title":"Pharmacotherapy for alcohol use disorder: a systematic review and meta-analysis","volume":"330","author":"McPheeters","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2025.110502_bib69","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/acer.12470","article-title":"Small-fiber degeneration in alcohol-related peripheral neuropathy","volume":"38","author":"Mellion","year":"2014","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110502_bib70","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/acer.13639","article-title":"Daily patterns of marijuana and alcohol Co-use among individuals with alcohol and cannabis use disorders","volume":"42","author":"Metrik","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110502_bib71","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0741-8329(92)90062-F","article-title":"Gender differences in the effects of ethanol on C57BL\/6 mice","volume":"9","author":"Middaugh","year":"1992","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2025.110502_bib72","article-title":"The predictive value of plasma bioactive lipids on craving in human volunteers with alcohol use disorder","volume":"4","author":"Miliano","year":"2024","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"10.1016\/j.neuropharm.2025.110502_bib73","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1360-0443.2012.04005.x","article-title":"Development of dependence following treatment with opioid analgesics for pain relief: a systematic review","volume":"108","author":"Minozzi","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2025.110502_bib74","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1073\/pnas.0730053100","article-title":"The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans","volume":"100","author":"Mogil","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110502_bib75","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/FBP.0000000000000553","article-title":"Effects of naltrexone on alcohol, sucrose, and saccharin binge-like drinking in C57BL\/6J mice: a study with a multiple bottle choice procedure","volume":"31","author":"Morales","year":"2020","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib76","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/acer.14949","article-title":"2-Arachidonoylglycerol-mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice","volume":"46","author":"Morgan","year":"2022","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110502_bib77","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1176\/appi.ajp.20230666","article-title":"Topiramate versus naltrexone for alcohol use disorder: a genotype-stratified double-blind randomized controlled trial","volume":"181","author":"Morley","year":"2024","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110502_bib78","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/mds.28681","article-title":"Monoacylglycerol lipase inhibition in tourette syndrome: a 12-week, randomized, controlled study","volume":"36","author":"Muller-Vahl","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2025.110502_bib79","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2019.02.020","article-title":"Molecular mechanism of action responsible for carrageenan-induced inflammatory response","volume":"109","author":"Myers","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib80","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2017.01.005","article-title":"Constitutive increases in amygdalar corticotropin-releasing factor and fatty acid amide hydrolase drive an anxious phenotype","volume":"82","author":"Natividad","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110502_bib81","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/acer.12774","article-title":"Evidence that melanocortin receptor agonist melanotan-II synergistically augments the ability of naltrexone to blunt binge-like ethanol intake in male C57BL\/6J mice","volume":"39","author":"Navarro","year":"2015","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110502_bib82","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/acer.13992","article-title":"Alone and in combination with naltrexone, blunts binge-like ethanol drinking and intake following chronic intermittent access to ethanol in male C57BL\/6J mice","volume":"43","author":"Navarro","year":"2019","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110502_bib83","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/cn400116z","article-title":"Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors","volume":"4","author":"Niphakis","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110502_bib84","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7326\/0003-4819-154-1-201101040-00008","article-title":"Integrating addiction medicine into graduate medical education in primary care: the time has come","volume":"154","author":"O'Connor","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuropharm.2025.110502_bib85","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrn4004","article-title":"Endocannabinoid signalling in reward and addiction","volume":"16","author":"Parsons","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110502_bib86","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/phar.2086","article-title":"The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, crohn's disease, and other chronic pain disorders","volume":"38","author":"Patten","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.neuropharm.2025.110502_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100149","article-title":"Sex differences in stress-related alcohol use","volume":"10","author":"Peltier","year":"2019","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.neuropharm.2025.110502_bib88","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108409","article-title":"The Sigma-2 receptor\/transmembrane protein 97 (sigma2R\/TMEM97) modulator JVW-1034 reduces heavy alcohol drinking and associated pain states in male mice","volume":"184","author":"Quadir","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110502_bib90","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/acer.14635","article-title":"Antagonism of Sigma-1 receptor blocks heavy alcohol drinking and associated hyperalgesia in male mice","volume":"45","author":"Quadir","year":"2021","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110502_bib91","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0055-23.2023","article-title":"Chronic alcohol drinking drives sex-specific differences in affective behavior and medial prefrontal cortex activity in CRF1:cre:tdTomato transgenic rats","volume":"10","author":"Quadir","year":"2023","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2025.110502_bib92","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/adb.12747","article-title":"Naltrexone effects on subjective responses to alcohol in the human laboratory: a systematic review and meta-analysis","volume":"24","author":"Ray","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib93","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/alcalc\/agv127","article-title":"Alcohol use disorders in primary health care: what do we know and where do we go?","volume":"51","author":"Rehm","year":"2016","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuropharm.2025.110502_bib94","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpain.2005.02.003","article-title":"Quantitative sensory testing: a comprehensive protocol for clinical trials","volume":"10","author":"Rolke","year":"2006","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2025.110502_bib95","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/adb.12360","article-title":"Intra-cerebral and intra-nasal melanocortin-4 receptor antagonist blocks withdrawal hyperalgesia in alcohol-dependent rats","volume":"22","author":"Roltsch Hellard","year":"2017","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib96","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1152\/physrev.00025.2008","article-title":"Models and mechanisms of hyperalgesia and allodynia","volume":"89","author":"Sandk\u00fchler","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110502_bib97","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1208\/s12248-008-9075-y","article-title":"Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation","volume":"11","author":"Schlosburg","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.neuropharm.2025.110502_bib98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2018.09.012","article-title":"Prevalence, incidence, recovery, and recurrence of alcohol use disorders from childhood to age 30","volume":"194","author":"Seeley","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110502_bib99","doi-asserted-by":"crossref","first-page":"9","DOI":"10.35946\/arcr.v42.1.09","article-title":"Alcohol-endocannabinoid interactions: implications for addiction-related behavioral processes","volume":"42","author":"Serrano","year":"2022","journal-title":"Alcohol Res"},{"key":"10.1016\/j.neuropharm.2025.110502_bib100","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/s41386-018-0055-3","article-title":"Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake","volume":"43","author":"Serrano","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110502_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060040","article-title":"Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism","volume":"8","author":"Starowicz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110502_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20031870","article-title":"Medications for the treatment of alcohol dependence-current state of knowledge and future perspectives from a public health perspective","volume":"20","author":"Stoklosa","year":"2023","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.neuropharm.2025.110502_bib103","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35843","article-title":"Support for expanding access to cannabis among physicians and adults with chronic pain","volume":"7","author":"Stone","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neuropharm.2025.110502_bib104","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/alcalc\/agt182","article-title":"Can cannabis be considered a substitute medication for alcohol?","volume":"49","author":"Subbaraman","year":"2014","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuropharm.2025.110502_bib105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ibneur.2022.08.004","article-title":"Alcoholic neuropathy associated with chronic alcohol intake","volume":"13","author":"Tessitore","year":"2022","journal-title":"IBRO Neurosci Rep"},{"key":"10.1016\/j.neuropharm.2025.110502_bib106","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/alcalc\/agx114","article-title":"Role of TLR4 in the modulation of central amygdala GABA transmission by CRF following restraint stress","volume":"53","author":"Varodayan","year":"2018","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuropharm.2025.110502_bib107","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1111\/bph.16197","article-title":"Sexually dimorphic effects of monoacylglycerol lipase inhibitor MJN110 on stress-related behaviour and drinking in Marchigian Sardinian alcohol-preferring rats","volume":"180","author":"Vozella","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.35946\/arcr.v40.2.01","article-title":"Gender differences in the epidemiology of alcohol use and related harms in the United States","volume":"40","author":"White","year":"2020","journal-title":"Alcohol Res"},{"key":"10.1016\/j.neuropharm.2025.110502_bib109","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/add.12964","article-title":"Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE study and the UK Alcohol Treatment Trial","volume":"110","author":"Witkiewitz","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2025.110502_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp8636","article-title":"A neural circuit for alcohol withdrawal-induced hyperalgesia in a nondependent state","volume":"10","author":"Yang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2025.110502_bib111","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2015990118","article-title":"Endogenous cannabinoids are required for MC4R-mediated control of energy homeostasis","volume":"118","author":"Yong","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110502_bib112","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","article-title":"The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain","volume":"33","author":"Younger","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.neuropharm.2025.110502_bib113","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1085-9489.2005.00050.x","article-title":"Large and small fiber neuropathy in chronic alcohol-dependent subjects","volume":"10","author":"Zambelis","year":"2005","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.neuropharm.2025.110502_bib114","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/JPR.S125987","article-title":"An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US","volume":"10","author":"Zeng","year":"2017","journal-title":"J. Pain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T16:06:49Z","timestamp":1749226009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825002084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":114,"alternative-id":["S0028390825002084"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110502","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.08.622656","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic intermittent ethanol produces nociception through endocannabinoid-independent mechanisms in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110502"}}